Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal R Swerdlow

Showing results (131-140 of 173) with videos related to

Pageof 18
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 19, 2022
EEG reveals that dextroamphetamine improves cognitive control through multiple processes in healthy participantsSavita G Bhakta, James F Cavanagh, Jo A Talledo, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|September 8, 2023
Effects of Memantine on the Auditory Steady-State and Harmonic Responses to 40 Hz Stimulation Across SpeciesNeal R Swerdlow, Christopher E Gonzalez, Muhammad Ummear Raza, et al.
Psychiatry Research|July 5, 2023
Mismatch negativity predicts initial auditory-based targeted cognitive training performance in a heterogeneous population across psychiatric disordersYash B Joshi, Christopher E Gonzalez, Juan L Molina, et al.
Journal of Alzheimer'S Disease : JAD|October 25, 2021
Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept DemonstrationNeal R Swerdlow, Juliana E Kotz, Yash B Joshi, et al.
Psychiatry Research|October 4, 2025
Do cognitive and neurophysiological effects of acute memantine "challenge" predict its clinical benefits in Alzheimer's Disease?Neal R Swerdlow, Joyce Sprock, Christopher E Gonzalez, et al.
Cognitive, Affective & Behavioral Neuroscience|January 3, 2024
Amphetamine increases motivation of humans and mice as measured by breakpoint, but does not affect an Electroencephalographic biomarkerMichael Noback, Savita G Bhakta, Jo A Talledo, et al.
Psychopharmacology|November 23, 2006
Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbitsKayla L Metzger, Jody M Shoemaker, Jonathan B Kahn, et al.
Psychopharmacology|February 8, 2022
Amphetamine alters an EEG marker of reward processing in humans and miceJames F Cavanagh, Sarah L Olguin, Jo A Talledo, et al.
Cell|August 6, 2013
Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical networkSuleyman Gulsuner, Tom Walsh, Amanda C Watts, et al.
Schizophrenia Research|May 3, 2016
Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family studySteven P Millard, Jane Shofer, David Braff, et al.
Pageof 18

Showing results (131-140 of 173) with videos related to

Sort By:
Pageof 18
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 19, 2022
EEG reveals that dextroamphetamine improves cognitive control through multiple processes in healthy participantsSavita G Bhakta, James F Cavanagh, Jo A Talledo, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|September 8, 2023
Effects of Memantine on the Auditory Steady-State and Harmonic Responses to 40 Hz Stimulation Across SpeciesNeal R Swerdlow, Christopher E Gonzalez, Muhammad Ummear Raza, et al.
Psychiatry Research|July 5, 2023
Mismatch negativity predicts initial auditory-based targeted cognitive training performance in a heterogeneous population across psychiatric disordersYash B Joshi, Christopher E Gonzalez, Juan L Molina, et al.
Journal of Alzheimer'S Disease : JAD|October 25, 2021
Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept DemonstrationNeal R Swerdlow, Juliana E Kotz, Yash B Joshi, et al.
Psychiatry Research|October 4, 2025
Do cognitive and neurophysiological effects of acute memantine "challenge" predict its clinical benefits in Alzheimer's Disease?Neal R Swerdlow, Joyce Sprock, Christopher E Gonzalez, et al.
Cognitive, Affective & Behavioral Neuroscience|January 3, 2024
Amphetamine increases motivation of humans and mice as measured by breakpoint, but does not affect an Electroencephalographic biomarkerMichael Noback, Savita G Bhakta, Jo A Talledo, et al.
Psychopharmacology|November 23, 2006
Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbitsKayla L Metzger, Jody M Shoemaker, Jonathan B Kahn, et al.
Psychopharmacology|February 8, 2022
Amphetamine alters an EEG marker of reward processing in humans and miceJames F Cavanagh, Sarah L Olguin, Jo A Talledo, et al.
Cell|August 6, 2013
Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical networkSuleyman Gulsuner, Tom Walsh, Amanda C Watts, et al.
Schizophrenia Research|May 3, 2016
Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family studySteven P Millard, Jane Shofer, David Braff, et al.
Pageof 18